OR-UCIE
2.3.2022 14:02:13 CET | Business Wire | Press release
Advanced Semiconductor Engineering, Inc. (ASE), AMD, Arm, Google Cloud, Intel Corporation, Meta, Microsoft Corporation, Qualcomm Incorporated, Samsung, and Taiwan Semiconductor Manufacturing Company today announced the formation of an industry consortium that will establish a die-to-die interconnect standard and foster an open chiplet ecosystem.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220302005254/en/
The organization, representing a diverse ecosystem of market segments, will address customer requests for more customizable package-level integration, connecting best-in-class die-to-die interconnect and protocols from an interoperable, multi-vendor ecosystem.
Universal Chiplet Interconnect Express (UCIe) Specification now available
The founding companies also ratified the UCIe specification, an open industry standard developed to establish a ubiquitous interconnect at the package level. The UCIe 1.0 specification covers the die-to-die I/O physical layer, die-to-die protocols, and software stack which leverage the well-established PCI Express® (PCIe®) and Compute Express Link™ (CXL™) industry standards. The specification will be available to UCIe members and available to download on the website.
Open for membership
The founding companies represent a wide range of industry expertise and include leading cloud service providers, foundries, system OEMs, silicon IP providers, and chip designers, and they are in the process of finalizing incorporation as an open standards body. Upon incorporation of the new UCIe industry organization later this year, member companies will begin work on the next generation of UCIe technology, including defining the chiplet form factor, management, enhanced security, and other essential protocols. To learn more about membership opportunities, contact admin@UCIexpress.org .
Resources:
About Universal Chiplet Interconnect Express (UCIe)
Universal Chiplet Interconnect Express (UCIe) is an open specification that defines the interconnect between chiplets within a package, enabling an open chiplet ecosystem and ubiquitous interconnect at the package level. Advanced Semiconductor Engineering, Inc. (ASE), AMD, Arm, Google Cloud, Intel Corporation, Meta, Microsoft Corporation, Qualcomm Incorporated, Samsung, and Taiwan Semiconductor Manufacturing Company are forming an open industry standard organization to promote and further develop the technology, and to establish a global ecosystem supporting chiplet design. For more information, visit www.UCIexpress.org .
PCI-SIG, PCI Express, and PCIe are registered trademarks of PCI-SIG. Compute Express Link™ and CXL™ Consortium are trademarks of the Compute Express Link Consortium. All other trademarks are the property of their respective owners.
Universal Chiplet Interconnect Express (UCIe) Promoter Statements of Support (Alphabetized by Company)
Advanced Semiconductor Engineering, Inc. (ASE)
“The age of Chiplets has truly arrived, driving the industry to evolve from silicon-centric thinking to system level planning and placing crucial focus on co-design of IC and package. We are confident that UCIe will play a pivotal role in enabling ecosystem efficiencies, by lowering development time and cost through open standards for interfaces between various IPs within a multi-vendor ecosystem as well as utilization of advanced package level interconnect. There is broad industry recognition that Heterogeneous Integration will help bring Chiplet-based designs to market. Given ASE’s expertise in packaging, assembly, and interconnect platform technology, we will provide UCIe with meaningful perspective to ensure forthcoming standards are practicable, complemented by commercially viable performance and manufacturing costs for package level manufacturing.”
Dr. Lihong Cao, Director of Engineering and Technical Marketing at ASE, Inc.
AMD
“AMD is proud to continue our long history of supporting industry standards that can enable innovative solutions addressing the evolving needs of our customers. We have been a leader in chiplet technology and welcome a multi-vendor chiplet ecosystem to enable customizable third-party integration. The UCIe standard will be a key factor to drive systems innovation leveraging heterogeneous compute engines and accelerators that will enable the best solutions optimized for performance, cost, and power efficiency.”
Mark Papermaster, Executive Vice President and Chief Technology Officer, AMD
Arm
“Interoperability is essential to removing fragmentation across the Arm ecosystem, and across the industry. By collaborating with other leaders in computing, Arm is committed to helping develop standards and specifications like UCIe to enable the system designs of our future.”
Andy Rose, chief system architect and fellow, Arm
Google Cloud
“An open, standards based chiplet ecosystem is an important enabler to foster Systems on Chip (SoC) designs as the integration point for an optimized system. Google Cloud is pleased to contribute to the Universal Chiplet Interconnect Express standard in service of the development of a multi-vendor inter-operable chiplet marketplace for the benefit of the industry.”
Partha Ranganathan, Google Fellow and Vice President
Intel Corporation
“Integrating multiple chiplets in a package to deliver product innovation across market segments is the future of the semiconductor industry and a pillar of Intel’s IDM 2.0 strategy. Critical to this future is an open chiplet ecosystem with key industry partners working together under the UCIe Consortium toward a common goal of transforming the way the industry delivers new products and continues to deliver on the promise of Moore’s Law.”
Sandra Rivera, Executive Vice President, Intel Corporation and GM, Data Center & AI
Meta
“Meta is excited to join UCIe as a founding member to enable and foster a standards-based die-to-die interconnect. Meta initiated ecosystem development to promote chiplet-based SOCs via the Open Compute Project (OCP) and is pleased to collaborate with other industry leaders via UCIe consortium for the ongoing and future success in this area.”
Vijay Rao, Directory of Technology and Strategy, Meta
Microsoft Corporation
“Microsoft is joining the UCIe industry organization to accelerate the pace of datacenter innovation and enable new breakthroughs in silicon design. We look forward to combining efforts of the organization with our own achievements to drive step-function improvements in silicon architecture for the benefit of our customers.”
Dr. Leendert van Doorn, Distinguished Engineer, Azure, Microsoft
Qualcomm Incorporated
“Qualcomm is pleased that the industry is coming together to form UCIe, which should move chiplet technology forward—an important technology to address the challenges in our increasingly complex semiconductor systems.”
Dr. Edward Tiedemann, Senior Vice-President, Engineering, Qualcomm Technologies, Inc.
Samsung
“Samsung envisions chiplet technology becoming necessary for performance gains in computing systems as process nodes continue to scale, with dies inside each package eventually communicating through a single language. We expect the UCIe Consortium to foster a vibrant chiplet ecosystem and establish the framework for a viable open-standard interface industry-wide. As a total solutions provider for memory, logic, and foundry, Samsung anticipates spearheading consortium efforts to further identify the best ways for enhancing system performance through chiplet technology.”
Cheolmin Park, Vice President of Memory Product Planning Team at Samsung Electronics
Taiwan Semiconductor Manufacturing Company
“TSMC is pleased to participate in this industry-wide consortium that will broaden the eco-system for package-level integration. TSMC offers various silicon and packaging technologies that provide multiple implementation options for heterogeneous UCIe devices.”
Lee-Chung Lu, TSMC Fellow and Vice President of Design and Technology Platform
View source version on businesswire.com: https://www.businesswire.com/news/home/20220302005254/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder28.4.2026 14:42:00 CEST | Press release
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145279/en/ Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right) Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, frequency, and incontinence. While intravesical botulinum toxin injection is an established second-line treatment, the invasive procedure limits patient access and acceptance. The ViXe program is desi
Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care28.4.2026 14:28:00 CEST | Press release
CTIBIOTECH™, a leading innovator in advanced human tissue engineering, proudly announces CTIONCOTEST™ platform is awarded Major Bpifrance Funding to Industrialize 3D Bioprinted Cancer Models CTIBIOTECH Announces the CTIONCOTEST ™ Project to Revolutionize Cancer Research with 3D Bioprinted Microtumors, Backed by France 2030 and Bpifrance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428242352/en/ The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the pla
BMG and Concord Combine to Create World’s Leading Independent Music Company28.4.2026 14:11:00 CEST | Press release
Creates global platform to deliver superior service to artists, songwriters, and partnersUnlocks meaningful value through greater scale and strong cash flow, enabling continued investment in music rights, creative talent, and technologyBob Valentine to serve as CEO and Thomas Coesfeld as Chairman of the combined company, with global headquarters in Nashville and European Headquarters in BerlinCombined company to be named BMG with divisions “BMG Publishing” and “Concord Records” BMG and Concord today announced a definitive agreement to combine their businesses, creating the leading independent music company in the world. Operating under the BMG name, the combined company will bring together two highly complementary businesses to establish a scaled, global company delivering superior service to artists, songwriters, and partners – firmly grounded in an independent, artist-first model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study28.4.2026 14:00:00 CEST | Press release
NICU Study Adds to the Evidence Demonstrating SET®’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation Categories or Race and Zero Occult Hypoxemia in Black or Hispanic Newborns Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical bias. Importantly, there were no clinically meaningful skin pigmentation-related discrepancies and no occult hypoxemic events among Black or Hispanic patients, and in only one Caucasian patient overall. The Neonatal Pulse Oximetry Accuracy and Disparities by Skin Pigmentation (NeoPODS) study findings were presented from the podium at the Pediatric Academic Society in Boston, MA on Monday, April 27th at 10 am EST by lead author Dr. Heather Siefkes on behalf of colleagues at the University of California, Davis and the University of Mississippi
KAYTUS AI Compute Pod Wins 2026 iF Design Award and Red Dot Award, Setting a New Standard for AI Data Center28.4.2026 11:54:00 CEST | Press release
Delivering up to 130kW of liquid cooling per rack, the solution synchronizes cooling output with IT load in real time within seconds, to support high-density AI, large-scale computing, and HPC deployments, while reducing build time by 70% KAYTUS, a leading provider in AI infrastructure and liquid-cooling solutions, announced that its AI Compute Pod has received both the 2026 iF Design Award and Red Dot Award. This dual recognition not only stems from its outstanding performance in green, low-energy operation—achieving up to 130 kW cooling capacity per rack and a PUE as low as 1.1 through optimized thermal and power design—but also from its innovative approach to intelligent control and efficient O&M. The solution enables second-level synchronization between cooling and IT workloads, and leverages a dual-group control strategy to improve cooling energy efficiency by over 10%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
